Genomic Expression, Inc.
Genomic Expression Inc is pioneering a next-generation RNA AI platform that enables personalized cancer treatment and drug discovery. Their OneRNA® platform analyzes all 20,000+ mRNAs in a patient's sample to identify the most effective treatments, offering a highly diagnostic yield and the potential to make cancer a treatable disease. The company is focused on individualizing cancer therapy, developing RNA therapeutics, and improving healthcare outcomes through advanced genomic analysis and AI-driven algorithms.
Industries
Nr. of Employees
small (1-50)
Genomic Expression, Inc.
Beverly, Massachusetts, United States, North America
Products
Comprehensive RNA analysis and clinical report
A clinical-grade assay and interpretive report that quantifies the tumor mRNA transcriptome and prioritizes approved drugs and relevant clinical trials for individual patients; intended to support treatment navigation.
Comprehensive RNA analysis and clinical report
A clinical-grade assay and interpretive report that quantifies the tumor mRNA transcriptome and prioritizes approved drugs and relevant clinical trials for individual patients; intended to support treatment navigation.
Services
Clinical RNA sequencing and treatment report service
End-to-end clinical sequencing of tumor tissue with interpretation that maps quantitative mRNA expression to potential approved therapies and clinical trials; reports delivered to treating clinicians.
Biomarker-driven drug development support
Consulting and execution support for drug developers to use comprehensive RNA profiles to derisk and accelerate clinical trials, develop algorithmic companion diagnostics, and define enrollment strategies (basket/umbrella studies).
RNA therapeutic design and translational services
Research and translational support to convert RNA expression signatures into designed RNA-based therapeutic constructs and envision rapid manufacture of individualized RNA therapeutics.
Clinical RNA sequencing and treatment report service
End-to-end clinical sequencing of tumor tissue with interpretation that maps quantitative mRNA expression to potential approved therapies and clinical trials; reports delivered to treating clinicians.
Biomarker-driven drug development support
Consulting and execution support for drug developers to use comprehensive RNA profiles to derisk and accelerate clinical trials, develop algorithmic companion diagnostics, and define enrollment strategies (basket/umbrella studies).
RNA therapeutic design and translational services
Research and translational support to convert RNA expression signatures into designed RNA-based therapeutic constructs and envision rapid manufacture of individualized RNA therapeutics.
Expertise Areas
- RNA sequencing-based diagnostics
- AI-driven treatment selection
- Drug repurposing for oncology
- Companion diagnostic algorithm development
Key Technologies
- Next-generation RNA sequencing (RNA-seq)
- FFPE-compatible RNA sample preparation
- AI / machine-learning diagnostic algorithms
- Drug–RNA expression mapping databases